SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE SEVENTH ANNUAL NEEDHAM & COMPANY, LLC BIOTECHNOLOGY AND MEDICAL TECHNOLOGY CONF

SAN DIEGO, CA, June 4, 2008 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX), a leading company focused on using proprietary taste receptor technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that the Company's Executive Vice President of Discovery & Development and CSO, Mark Zoller, Ph.D.; Vice President of Finance and Treasury, Tony Rogers; and Vice President of Investor Relations & Corporate Communications, Gwen Rosenberg, will present a corporate overview on Wednesday, June 11, at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) during the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference. The conference is taking place at the New York Palace Hotel. The presenters will discuss the Company's status and pipeline of novel flavor ingredients.

To access the live presentation or a subsequent archived recording, please log onto Senomyx's website at http://www.senomyx.com and click on the "Investor Relations" tab. The archived webcast will be available for 30 days following the presentation. Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to download any software that may be necessary.

About Senomyx, Inc. (http://www.senomyx.com)

Senomyx is a leading company using proprietary taste receptor technologies to discover and develop novel flavor ingredients in the savory, sweet, salt, bitter, and cooling areas. Senomyx has entered into product discovery and development collaborations with seven of the world's foremost food, beverage, and ingredient supply companies: Ajinomoto Co., Inc., Cadbury plc, Campbell Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA, and Solae. Nestle is currently marketing products that contain one of Senomyx's flavor ingredients. For more information, please visit http://www.senomyx.com.

SOURCE Senomyx, Inc.